QurCan Therapeutics

Profile

QurCan Therapeutics is advancing the next wave of genetic medicines for CNS diseases with TERP (Target-Engineered Responsive Polymer) technology, a non-viral delivery platform enabling safe, repeat intravenous delivery of RNA and biologics to the brain.

Website

qurcan.com

Contact


Event details

Date: October 7 - 9, 2026

Event contact

Stephen Ip
Senior International Market Consultant
Japan and Korea

Participants

<?php global $lang_id; switch ($lang_id) { case "fr": echo 'Total de 13'; break; case "pt-br": echo 'Total de 13'; break; case "es": echo 'Total de 13'; break; case "ja": echo '13 合計'; break; case "ko": echo '13 총계'; break; case "en": default: echo '13 in total'; break; } ?>